July 14, 2022 10:44 AM EDT

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Hal Barron’s anti-aging biotech has added Vir Biotechnology CSO Herbert “Skip” Virgin to its ranks. At the Rick Klausner-founded Altos Labs, Virgin will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Sign up to read this article for free.

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Vir CSO de­part­ing next month to be Al­tos CMO; Bob Dug­gan’s Sum­mit Ther­a­peu­tics and the FDA try to make head­way

Senior Reporter

News Reporter

Sign up to read this article for free.

Vir CSO departing next month to be Altos CMO; Bob Duggan’s Summit Therapeutics and the FDA try to make headway